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MicroarraysHEp-2 cells that survived a lytic infection with Human Respiratory Syncytial Virus (HRSV) were grown to
obtain a persistently infected culture that produced relatively high amounts of virus (106–107 pfu/ml) for
more than twenty passages. The cells in this culture were heterogeneous with regard to the expression of
viral antigens, ranging from high to undetectable levels. However, all cell clones derived from the persistent
culture did not produce infectious virus or viral antigens and grew more slowly than the original uninfected
HEp-2 cells. When these “cured” cell clones were infected with wild-type HRSV, delayed virus production
and reduction in the number and size of syncytia were observed compared to lytically infected HEp-2 cells.
Most signiﬁcantly, differences in gene expression between persistently and lytically infected cultures were
also observed, including genes that encode for cytokines, chemokines and other gene products that either
promote cell survival or inhibit apoptosis. These results highlight the signiﬁcantly different responses of the
same cell type to HRSV infection depending on the outcome of such infection, i.e., lytic versus persistent.
© 2009 Elsevier Inc. All rights reserved.Introduction
HRSV is a member of the Pneumovirus genus of the Paramyxoviri-
dae family (order Mononegavirales). It is an enveloped virus with a
single-stranded negative-sense RNA genome of approximately 15 kb
that encodes 11 known proteins (Collins and Crowe, 2007). Three of
those viral products are transmembrane suface glycoproteins, namely
the attachment glycoprotein (G), the fusion (F) protein, and the small
hydrophobic (SH) protein. An additional protein, the matrix protein
(M), localizes in the inner surface of the envelope and plays a major
role in virion morphogenesis. Five other HRSV proteins are involved in
nucleocapsid structure and/or RNA synthesis: these are the nucleo-
protein (N), the polymerase (L), the phospoprotein (P), and the M2-1
and M2-2 proteins. The two remaining HRSV proteins, NS1 and NS2,
are non-structural proteins involved in counteracting the host innate
response to infection.
HRSV, for which neither a vaccine nor an effective therapeutic
treatment is currently available, is a common cause of acute
respiratory infections that may lead to serious illnesses such asll rights reserved.bronchiolitis and pneumonia in infants, the elderly and the
immunocompromised adults (Collins and Crowe, 2007). Available
evidence supports the notion that much of the pathogenesis
associated to HRSV infections is due to an inadequate immune
response. Infected epithelial cells secrete cytokines, chemokines and
other factors that determine subsequent adaptive immunity and lead
to pulmonary inﬂammation (Culley et al., 2006; Krishnan et al.,
2004). Besides these acute manifestations of HRSV infection,
sequelae such as recurrent wheezing and asthma symptoms may
develop after infantile bronchiolitis (Perez-Yarza et al., 2007). Virus
persistence in humans has been proposed to explain not only these
sequelae, but also virus maintenance between seasonal epidemics,
since no animal reservoir has been described for this virus. Persistent
infections of HRSV have been established in several human and
animal cell lines of either epithelial or immune origin (Baldridge and
Senterﬁt, 1976; Bangham and McMichael, 1986; Fernie et al., 1981;
Guerrero-Plata et al., 2001; Hobson and Everard, 2007; P'Ringle et al.,
1978; Panuska et al., 1990; Peeples and Levine, 1981; Sarmiento et al.,
2002; Tirado et al., 2005; Valdovinos and Gomez, 2003). Circum-
stantial evidence has been provided also for persistence of HRSV in
laboratory animals such as mice and guinea pigs (Hegele et al., 1994;
Schwarze et al., 2004; Streckert et al., 1996). In addition, some
Fig. 1. (A) Cytopathic effect of persistent HRSV infection on HEp-2 cells at passages 4, 13 and 26. A frozen stock was made shortly after establishing the persistent culture, which was
designated “passage 0”. Succesive 1/3 passages were doneweekly. (B) Virus production by persistently infected cells at different passages. Cells growing for three days in unchanged
culture mediumwere scrapped off, disaggregated by thoroughly pippeting, and virus titer was determined in the clariﬁed supernatant by plaque assay using a mixture of anti-G and
anti-F glycoprotein antibodies. (C) Comparison of HRSV internal and surface protein expression in persistently and lytically infected cells. Total protein cell extracts were made from
persistently (passage four) and lytically HRSV infected cells (MOI 1, 24 h post-infection), fractionated by SDS-PAGE and visualized by western-blotting using antibodies against the
surface glycoproteins G (021/19G) and F (αF255–275), or the nucleocapsid proteins N (79N) and P (67P). 1, lytically and 2, persistently infected cells.
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in humans. For example, 1) HRSV antigens were detected in bone
biopsies and in cells cultured from Paget disease bone lesions (Mills
et al., 1981), 2) prolonged virus shedding was observed in
immunocompromised persons (Couch et al., 1997), 3) HRSV could
be isolated repeatedly from the nasopharynx of apparently healthy
children for a period of up to 5 months (Isaia et al., 1985), 4) virus
nucleic acid was detected in archival postmortem lung tissue from
summer infant deaths even though no clinical disease was observed
(Cubie et al., 1997), and 5) persistent HRSV infection appears to occur
in certain individuals with chronic obstructive pulmonary disease
(COPD) (Wilkinson et al., 2006).
Continuous stimulation of the immune system by persistent virus
infections may cause chronic inﬂammation (Di Rosa and Barnaba,
1998; Kim et al., 2008) or changes in the expression of immunor-
egulatory molecules (Guerrero-Plata et al., 2001; Wald et al., 2007)
that may explain the clinical symptoms persisting long after some
acute viral infections. In the guinea pig model, an association between
long-term persistence of HRSV infection and airway hyperrespon-
siveness and eosinophiliawas observed (Bramley et al., 1999; Riedel et
al., 1997), and persistent detection of HRSV RNA from lower airway
samples of patients with COPD has been recently associated with
greater airway inﬂammation (Wilkinson et al., 2006).
Here we describe HEp-2 cultures persistently infected with the
Long strain of HRSV at early passages of infection. When compared
with the same cells lytically infected by this virus, differences in the
expression of certain chemokines, cytokines, apoptosis and cell
survival promoting genes were observed. Therefore, and besides its
possible in vivo relevance, infection of HEp-2 cells with HRSV
constitutes an attractive model to study the molecular interactions
that determine either persistence or a lytic outcome of the same
virus–host cell system.Results
HEp-2 cells persistently infected with the Long strain of HRSV
were obtained as an outgrowth of a few cells surviving an HRSV
lytic infection: HEp-2 cells were infected with the Long strain at a
multiplicity of infection (MOI) of 3 pfu/cell. After 72 h of infection
most cells had already died and detached from the plastic but a
few of them remained attached. These cells were supplied with
fresh medium until a monolayer was formed. Then, they were
passed 3 times at a 1/2 dilution before making a frozen stock,
which was designated “passage 0”. Successive 1/3 passages were
done weekly.
After an initial characterization of the persistent culture, our study
has focused on the cellular response at early stages of the persistent
infection (between passages four and six), to gain insight into the
cellular mechanisms involved in the establishment of this type of
culture, as well as into the innate immune response triggered in
infected cells.
Cytopathic effect and virus production in the culture of HEp-2 cells
persistently infected with HRSV
Shortly after the establishment of the persistent culture, large
syncytiawere observed, alongwith small groups of non-syncytial cells
that appeared to originate from single cells (Fig. 1A, P4). However, as
cells were passaged, the number and size of syncytia decreased (Fig.
1A, P4–P26).
Despite the above mentioned differences in the cytopathic effect,
relatively high titers of virus (106–107 pfu/ml) were produced, with
no major variations, during more than twenty passages (Fig. 1B).
Thus, this situation is different to those described for persistent
infections with other viruses, in which low level of virus production
Fig. 2.Heterogeneity in the expression of HRSV antigens in persistently infected cells. (A) Expression of the virus surface glycoproteins G and F and the nucleocapsid proteins N and P
was visualized by immunoﬂuorescence with the monoclonal antibodies 021/19G, 47F, 79N and 67P, respectively, in persistently (passage 6) and lytically (MOI 5, 24 h p.i.) infected
HEp-2 cells. (B) Flow cytometry analysis of uninfected, persistently (passage 6) and lytically (MOI 5, 24 h p.i.) infected cells with an anti-F-Cy5 conjugated antibody.
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observed (Fernie et al., 1981; Hodes et al., 1979; Inglot et al., 1973;
Palma and Huang, 1974).
We have previously reported that, compared to a lytic infection,
there were changes in the accumulation or the electrophoretic
mobility of some viral proteins in a cell line of mouse ﬁbroblasts
persistently infected with HRSV (Martinez et al., 2001). In contrast, no
discernible differences were observed by western-blotting between
the G, F, N and P HRSV proteins obtained from either lytically or
persistently infected HEp-2 cell cultures (Fig. 1C). This result, along
with the observation that the production of virus in the persistent
infection of mouse ﬁbroblasts is very low (Fernie et al., 1981),
indicates that the mechanisms underlying HRSV persistence in mouse
cells and in HEp-2 cells are very different.Cell clones recovered from the persistent culture were uninfected
Immunoﬂuorescence of the persistently infected HEp-2 cell
culture with monoclonal antibodies directed against any of four
HRSV proteins (G, F, N and P) revealed signiﬁcant heterogeneity in the
expression level of viral antigens among individual cells, compared
with a lytically infected culture (Fig. 2A). Although a signiﬁcant
proportion of cells were positive for HRSV antigens in the persistently
infected culture, large differences in the ﬂuorescence intensity of
individual cells were observed and some cells were apparently
negative, regardless of the monoclonal antibody used. Flow cytometry
analysis with anti-F antibodies conﬁrmed these results and showed
large heterogeneity in antigen expression levels, with approximately
one third of the cells being negative, in persistently infected cultures,
Fig. 3. Characterization of cells cloned from the persistent culture. (A) Growth rate of parental HEp-2 cells and clones derived from the persistent culture: 3×106 cells were seeded in
90 mm dishes and incubated at 37 °C. At the indicated times, cells were trypsinized and counted. Clones 4C1 to 4C4 were obtained from passage four of the persistent infection. (B)
Cytopathic effect of wild-type Long HRSV in HEp-2 cells and cells cloned from the persistent culture. Cells were infected at a MOI of 1 pfu/cell and photographed at 24 h p.i. (C) Virus
yield 24 h after infection of cells cloned from the persistent culture with the wild-type Long HRSV at a MOI of 1 pfu/cell. Virus titers were determined by plaque assay with a mixture
of anti-G and anti-F antibodies and expressed as a percentage of the titer from infected HEp-2 cells. Mean and standard deviation of three independent experiments are shown. (D)
Flow cytometry analysis of uninfected (white), and lytically infected (black) (MOI 1, 24 h p.i.) HEp-2 and 4C3 cells with an anti-F-Cy5 conjugated antibody.
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lytically infected cells (Fig. 2B).
In light of these ﬁndings, the persistently infected cells were
cloned at passage four by two rounds of limited dilution. In brief, cells
were trypsinized and serial two-fold dilutions were plated in 96-well
microplates. Wells were monitored daily for cell growth and those at
the highest dilution that showed individual clones were trypsinizedagain and replated as before. After this second round of cloning, cells
in the selected wells (those from the highest dilution showing a single
clone) were trypsinized and expanded for further studies. All clones
showed no morphological signs of infection, were negative for HRSV
antigens by immunoﬂuorescence, did not produce detectable virus,
and no product was ampliﬁed by RT-PCR with primers against a
conserved region of N which could be readily ampliﬁed from RNA of
Fig. 4. Flow cytometry of cells after magnetic sorting of the persistently infected culture.
Dot plots (size, FSC-H, versus ﬂuorescence intensity) of cells stained with antibodies
against the F and G HRSV glycoproteins, followed by goat anti-mouse Ig-R-
Phycoerythrin, from either the HRSV persistently infected culture (persistent, passage
6) or after sorting, using MS columns as described in Materials and methods. The
retained (cells positive for virus antigens) and non-retained (mostly cells negative for
virus antigens) fractions were analyzed immediately after sorting or after 21 days in
culture (days post-sorting, dps). Uninfected cells were used as negative control
throughout the experiment.
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were morphologically distinguishable from each other and from
uninfected HEp-2 cells under light microscopy, indicating that the
persistent culture contained several cell variants.Four clones derived from the HRSV persistently infected culture
were selected for further analysis. All these clones grew more
slowly than the original HEp-2 cells under standard culture
conditions. Whereas the duplication time was 28 h for uninfected
HEp-2, it was between 37 and 46 h for the clones (Fig. 3A). When
these cells were lytically infected with wild-type HRSV, signiﬁcant
differences were observed relative to lytically infected HEp-2.
While large syncytia were clearly visible in HEp-2 cells at 24 h p.i.
with a MOI of 1 pfu/cell, the number and, particularly, the size of
syncytia were decreased in the four clones (Fig. 3B). In addition,
the production of virus was reduced approximately four-fold
compared to lytically infected HEp-2 cells by that time (Fig. 3C).
Flow cytometry analysis of the infected clones showed that the
production of F protein was also lower compared to lytically
infected HEp-2 cells (Fig. 3D), indicating that the step at which
virus production is restricted in the cell clones is previous to the
formation of viral particles.
Since no positive cell clones for HRSV were selected from the
persistent culture, it could be hypothesized that virus positive cells
could not survive by themselves and needed less permissive cells to be
maintained in the persistent culture. Cloning is a very strong selective
process that might kill infected cells, therefore a more gentle protocol
was used to separate HRSV positive from negative cells by three
rounds of magnetic cell sorting (see Materials and methods). A
homogeneous population of highly positive cells was eluted from the
column, as assessed by ﬂow cytometry (Fig. 4, retained). These cells
were incubated under the same conditions as the original persistently
infected culture. Although substantial cell death was observed
initially, the surviving cells proliferated and became much more
heterogeneous with regard to the viral antigen expression than those
eluted from the column, as revealed by ﬂow cytometry 21 days after
sorting (Fig. 4, retained 21 dps). The cells that were not retained in the
column were mostly negative for viral antigen (Fig. 4, non-retained).
However, after 21 days in culture, these cells were again highly
heterogeneous for viral antigen expression (Fig. 4, non-retained
21 dps) and resembled the culture started with the highly positive
cells (Fig. 4, compare panels “retained” and “non-retained” 21 dps).
Furthermore, the heterogeneity of antigen expression in these two
cultures was similar to that seen in the persistently infected culture
before sorting (Fig. 4, persistent). These results demonstrate that
highly positive cells of the persistently infected culture can survive by
themselves and regenerate a heterogeneous cell population for viral
antigen expression. In addition, they indicate that negative cells are
susceptible to HRSV infection and can reach high levels of antigen
expression.
Analysis of gene expression in the persistently infected cell culture
Gene expression was analyzed at early passages of persistently
infected cells by DNA microarrays and compared to cells lytically
infected by the Long strain of HRSV after 24 h of infection. In both
cases, mRNAs were reverse-transcribed to Cy5-dUTP-cDNAs, mixed
with control Cy3-dUTP-cDNAs from non-infected cells and competi-
tively hybridized to the 12 K human CNIO microarray (see Materials
and methods). Three independent experiments were performed, and
differentially expressed genes were identiﬁed in each case using SAM
2.0 software (Tusher et al., 2001). Only the most signiﬁcant changes
were considered (q-values ≤1%). Differences in the expression of a
particular gene between persistently infected cells and lytically
infected cells were determined by the formula: mean Log2 (R/G) in
persistently infected cells−mean Log2 (R/G) in lytically infected cells
(see Materials and methods). Genes with values ≥1 (two or more
times up-regulated in persistent versus lytic infections) and ≤−1
(two or more times down-regulated in persistent versus lytic
infections) were selected for further analysis (Supplementary Table
S1). Following these criteria, 97 genes were up-regulated (between 2
Fig. 5. Persistent HRSV infection and apoptosis. (A) Microarray analysis of differentially expressed genes related to apoptosis in lytic and persistently infected HEp-2 cells. Data
represent the mean and standard deviation from three independent experiments. R, red ﬂuorescence intensity emission of Cy5-dUTP (lytically or persistently infected samples); G,
green ﬂuorescence intensity emission of Cy3-dUTP (uninfected samples). RNA from lytic infections was extracted at 24 h p.i. (MOI 3) and RNA from persistent infections was
extracted at passages 4, 5 and 6. (B) Expression of caspases-3, -8 and -9 in persistently infected (passage 6) and lytically infected cells (MOI 3, 24 h p.i.). Ten micrograms of total
proteins from the corresponding cell extracts were fractionated by SDS-PAGE and visualized by western-blotting with speciﬁc antibodies. An antibody against β-actin (ACTB) was
included as an internal control. (C) Activation of caspase-9 by UV irradiation. Cells were irradiated for 3 min with UV light, incubated a 37 °C for the time indicated at the bottom of
each lane (hours) and protein extracts were made and analyzed bywestern-blotting with speciﬁc antibodies. Caspase-9 activationwas visualized by detection of its cleaved products
of 37 and 35 kDa. The amount of extract loaded from persistenly infected cultures (passage 6) was double that from uninfected cells. (D) DNA fragmentation in cells irradiated with
UV light. Cells were irradiated with UV light for 3 min, incubated for 3 h at 37 °C, DNA was extracted and 3 μg were loaded into a 1.7% agarosa gel and visualized with ethidium
bromide (left). Alternatively, DNA fragmentation was determined by ELISA (right; see Materials and methods). Lytic infections were carried out at a MOI of 3 pfu/cell and cells were
irradiated at 24 h p.i. Persistent cells were irradiated at passage 6.
36 I. Martínez et al. / Virology 388 (2009) 31–41and 13 times) in persistent infections when compared to lytic
infections, and 74 were down-regulated (between 2 and 34 times)
(Supplementary Table S1).
Genes that were up- or down-regulated could be classiﬁed in
diverse functional categories (Supplementary Table S2). These data
showed that the mRNA levels of some cytokines differed between
persistent and lytic infections. In addition, persistently infected
cells appeared to modulate the expression of several genes
involved in cell survival, such as some of those affecting integrin-
mediated signaling and apoptosis inhibition. Due to the likely
implication of the above mentioned genes in the maintenance of
HRSV persistence, further experiments were carried out to conﬁrm
and extend these results.Inhibition of apoptosis and activation of integrin-mediated signaling
may contribute to persistently infected cell survival
Apoptosis and virus infection are intimately related in many
cases. Host cells respond to virus infection by triggering apoptosis
to minimize viral replication and spreading. Thus, it is not
surprising that many viruses have evolved mechanisms to inhibit
such programmed cell death (Hay and Kannourakis, 2002). In the
case of HRSV, inhibition of apoptosis occurs at early times post-
infection but not at later times, leading eventually to cell death
(Bitko et al., 2007; Groskreutz et al., 2007; Lindemans et al., 2006;
Monick et al., 2005; Thomas et al., 2002). A different scenario
emerges from persistent infections, in which most cells survive. In
Fig. 6. Integrin-mediated signaling in HRSV infected cells. (A) Microarray analysis of differentially expressed genes related to integrin-mediated signaling in lytic and persistently
infected HEp-2 cells. Data represent the mean and standard deviation from three independent experiments. R, red ﬂuorescence intensity emission of Cy5-dUTP (lytically or
persistenly infected samples); G, green ﬂuorescence intensity emission of Cy3-dUTP (uninfected samples). RNA from lytic infections was extracted at 24 h p.i. (MOI 3) and RNA from
persistent infections was extracted at passages 4, 5 and 6. (B) Expression of CD47, ITGB5 and ITGAV in persistently infected (passage 6) and lytically infected cells (MOI 3, 24 h p.i.).
Ten micrograms of the total protein extracted from the indicated cells was fractionated by SDS-PAGE and visualized by western-blotting with speciﬁc antibodies. An antibody against
β-actin (ACTB) was included as an internal control.
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Microarray analysis revealed the upregulation of antiapoptotic
genes such as those encoding for TNF receptor associated factor
1 (TRAF1) and baculoviral IAP repeat-containing 3 (BIRC3/cIAP2)
proteins in the persistently infected HEp-2 cells; and the down-
regulation of proapoptotic genes such as TNF-α, BCL2-like 11
(apoptosis facilitator) (BCL2L11/BIM) and caspase-9 (Fig. 5A).
Particularly striking was the case of caspase-9, a key component
of the intrinsic or mitochondrial apoptotic pathway (Danial and
Korsmeyer, 2004), for which mRNA levels were even below those
of non-infected cells. To conﬁrm this result, the accumulation of
CASP3, CASP8 and CASP9 was analyzed by western-blotting in
uninfected, lytically infected and persistentely infected cells. In
agreement with microarray data, the levels of CASP9 were reduced
only in persistent cells compared to mock or lytically infected cells
(Fig. 5B). However, activation of CASP9, as indicated by its
cleavage, was observed in non-infected as well as in persistently
infected HEp-2 cells irradiated with UV light and, in both cases, the
kinetics of activation were similar (Fig. 5C). It should be noted that,
in order to visualize the cleaved fragments, the amount of total
protein loaded from the persistent cells was two-times that from
non-infected cells.
The imbalance, revealed by the microarray analysis, between
proapoptotic and antiapoptotic genes in the persistently infected
culture indicated that apoptosis was inhibited, at least in part, in theseFig. 7. Chemokine expression in HRSV infected cells. (A) Microarray analysis of differentially e
the mean and standard deviation from three independent experiments. R, red ﬂuorescenc
ﬂuorescence intensity emission of Cy3-dUTP (uninfected samples). RNA from lytic infections
passages 4, 5 and 6. (B) Accumulation of CCL2, CCL3 and CCL5 chemokines in the supernata
determined by solid phase sandwich ELISA as described in Materials and methods (L, lytic; P
experiments.cells. To conﬁrm this, uninfected, lytically infected and persistently
infected HEp-2 cell were irradiated with UV light to induce apoptosis,
and DNA fragmentation was visualized on agarose gels by ethidium
bromide staining. As expected from the microarray data, the
persistently infected cells were more resistant to DNA fragmentation
than lytically infected cells which, in turn, were more resistant than
uninfected cells (Fig. 5D). These results were further conﬁrmed in a
different experiment by an ELISA for nucleosomal DNA fragmentation
(Fig. 5D).
Another set of upregulated genes in persistently infected cells
that may be involved in cell survival are those of some integrins
and integrin-mediated signaling. Integrins are noncovalently asso-
ciated αβ-heterodimeric cell surface adhesion receptors that bind
to extracellular matrix, cell-surface and soluble ligands (Takada et
al., 2007). Binding of ligands to integrins triggers a variety of
intracellular signals that modulate cell behavior, including prolif-
eration, migration, survival and apoptosis, mostly through interac-
tion with the cytoskeleton. In persistently infected cells, several
genes related to integrin signaling were upregulated when
compared to a lytic infection of HRSV. Those genes included the
alpha-V (ITGAV) and beta-5 (ITGB5) integrin subunits, CD47 and
vitronectin (VTN) (Fig. 6A). Interestingly, ITGAV, ITGB5 and CD47
are downregulated in lytic infections (Fig. 6A). These results from
microarray analysis were also conﬁrmed at the protein level for
selected genes (Fig. 6B).xpressed chemokine genes in lytic and persistently infected HEp-2 cells. Data represent
e intensity emission of Cy5-dUTP (lytically or persistently infected samples); G, green
was extracted at 24 h p.i. (MOI 3) and RNA from persistent infections was extracted at
nt of lytically (MOI 3, 24 h p.i.) and persistently (passages 4, 5 and 6) infected cells was
, persistent). Data represent the mean and standard deviation from three independent
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expression
HRSV infection increases secretion of several chemokines that
attract immune cells to the site of infection leading to lung
inﬂammation (Thomas et al., 2007). The pattern of chemokine
expression may determine the nature of the pulmonary cellular
inﬁltrate and, hence, the extent of inﬂammation (Culley et al., 2006).
In addition, the upregulation and/or downregulation of some
cytokines has been shown to favor the establishment of virus
persistence (Brooks et al., 2006; Ejrnaes et al., 2006). When the
expression of cellular genes in lytic and persistent HRSV infections
was compared using cDNA microarrays, an imbalance in the
expression of certain chemokines was observed. For example,
whereas the mRNA levels of CCL3 (MIP-1α), CCL3L1, CCL5 (RANTES)
and CXCLl0 (IP-10) were higher in persistently infected cells than in
lytically infected cells, the result was the opposite for CCL2 (MCP-1). In
this case, the amount of mRNA in persistently infected cells was even
lower than in uninfected HEp-2 cells (Fig. 7A). To conﬁrm this, the
production of the chemokines CCL2, CCL3 and CCL5 was analyzed by
ELISA in the culture supernatant of persistent and lytic infections (Fig.
7B). Again, while CCL5 and CCL3 were overexpressed in persistent
cultures, the amount of CCL2 protein in the supernatant of these
cultures was lower than in non-infected cells (Fig. 7B). Although the
up-regulation of all those chemokines has been extensively described
in many HRSV infections, the striking differences in their level of
expression between persistently and lytically infected cells have not
been reported previously and deserve further investigation.
Discussion
Persistent infections of HRSV, both in vitro and in vivo, have been
reported, however few studies have addressed the underlying
mechanisms of such infections. Since no animal reservoir has been
described for this virus, the persistence of HRSV in humans has been
suggested to facilitate virus survival between epidemics. Recently, the
possible implication of HRSV persistence in the development of
chronic respiratory diseases has renewed interest in this type of
infection (Tan et al., 2008; Wilkinson et al., 2006).
The work reported here is the ﬁrst attempt to compare the
response of the same cell to either a persistent or a lytic infection by
HRSV, focusing on the analysis of early passages of persistently
infected cells to identify critical cellular changes involved in the
establishment of this type of infection and differences in the cellular
innate immune response.
Although a substantial proportion of the HEp-2 cells in the
persistently infected culture were positive for HRSV antigens, not all
of them expressed the same amount of antigen at a given time point.
Cells expressing high amounts of virus antigens coexisted with cells
expressing low or undetectable levels of antigens. It can be concluded,
therefore, that the culture was persistently infected, since it could be
maintained during successive passages producing relatively high
amounts of virus, although all cells may not be persistently infected in
a strict sense. Indeed, all the cell clones isolated from the persistently
infected culture were negative for virus and antigen production.
Whether these clones came from uninfected cells or were sponta-
neously “cured” during the cloning process, remains to be determined.
In fact, the observation that the cell clones were morphologically
distinguishable from each other and that they showed a slower
growth rate and partial resistance to virus replication and syncytia
formation than the original HEp-2 cells suggests that cell variants,
partially resistant to HRSV, were selected during the establishment of
persistence. A similar scenario has been reported for foot-and-mouth
disease virus, for which it was suggested that cell heterogeneity would
confer a selective advantage for virus and cell survival in persistent
infections (de la Torre et al., 1989). A dynamic interaction may then beenvisaged between HRSV and the selected cell variants of HEp-2 cells
to establish persistence. In fact, the results obtained with cells sorted
for viral antigen expression support this notion. Either highly positive
cells or cells that expressed low or undetectable levels of viral
antigens, regenerated persistent cultures that were much more
heterogeneous with regard to the HRSV antigen expression.
Other factors that may contribute to establishment of a HRSV
persistent infection (e.g. accumulation of defective interfering
particles) cannot be ruled out. However, no compelling evidence
was found for DI particles in the supernatant of the persistently
infected HEp-2 culture (not shown), in agreement with the estab-
lished idea that HRSV is not prone to the generation of this type of
interference particles.
Differences in cell gene expressionwere detected between lytically
and persistently infected cultures that could not be explained by just a
simple mixture of infected and non-infected cells. Therefore, HRSV
lytic and persistent infections of the same cell type are not equivalent
in several aspects of cellular physiology. For example, HRSV
persistence may be facilitated by the upregulation of prosurvival
genes and inhibition of apoptosis in the persistent culture. Although
premature apoptosis is suppressed in epithelial cells by the HRSV
nonstructural proteins through the activation of the PI3K/AKT/NF-κB
pathway (Bitko et al., 2007; Thomas et al., 2002), the virus activates
apoptosis at late stages of a lytic infection (Monick et al., 2005;
O'Donnell et al., 1999). In order to survive, apoptosis must be
controlled in persistently infected cells, at least to a certain point.
The fact that those cells are resistant to DNA fragmentation by UV
light, along with the up-regulation of antiapoptotic genes (TRAF1,
BIRC3/cIAP2) and downregulation of proapoptotic genes (TNF-α,
BCL2L11/BIM, CASP9), clearly indicates that apoptosis is, to a large
extent, inhibited in those cells. It has been reported that the Bim
protein, a protein that belongs to the BCL-2 pro-apoptotic protein
family, is downregulated in HRSV infection, contributing to delay of
apoptosis (Monick et al., 2005). A remarkable result from the
persistent infection is the downregulation of caspase-9, a key initiator
of the intrinsic or mitochondrial apoptotic pathway (Danial and
Korsmeyer, 2004), a pathway activated during HRSV induced cell
death (Eckardt-Michel et al., 2008). Thus, it is likely that dowregula-
tion of caspase-9, along with the other above mentioned changes in
gene expression, may contribute to the resistance of persistently
infected cells to apoptosis.
Additional mechanisms that may promote cell survival in
persistently infected cells relay on integrin signaling. Integrins are
noncovalently associated heterodimeric (α/β) cell surface adhesion
molecules. In humans there are 18 α subunits and 8 β subunits that
form at least 24αβ pairs, each of which binds to a speciﬁc and limited
subset of extracellular matrix (ECM) and/or cell surface ligands (Luo
et al., 2007). Integrin binding to ECM ligands is essential for cell
survival, thus it is not surprising that both integrins andmatched ECM
ligands are usually coexpressed in the same microenviromment.
Integrin–ligand interaction triggers cell spreading on the substrate,
increasing cell resistance to apoptosis and promoting cell survival
(Stupack, 2005). In this regard, it is worth noting that both the αVβ5
integrin and its ECM ligand vitronectin are upregulated in persisetenly
infected cells.
Persistent HRSV infection of the lung may lead to prolonged
inﬂammation and chronic respiratory disease (Bramley et al., 1999;
Seemungal et al., 2001; Tan et al., 2008; Wilkinson et al., 2006). A
continuous and/or imbalanced production of some cytokines may
contribute to that scenario. Thus, increased levels of IL-6 and IL-8 are
associated with HRSV detection in chronic obstructive pulmonary
disease (COPD) (Seemungal et al., 2001; Wilkinson et al., 2006), and
with HRSV persistent infections of epithelial andmacrophage-like cell
lines (Guerrero-Plata et al., 2001; Tirado et al., 2005). Along with the
upregulation of CCL3 and CCL5, high levels of IL-8 and IL-6 were also
detected in the culture supernatant of HEp-2 cells persistently
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was the downregulation of the expression of CCL2 (MCP-1) in the
persistent culture. CCL2 is a chemokine expressed at high levels in
HRSV infections that promotes recruitment of mononuclear phago-
cytes, T lymphocytes, and NK cells to the site of infection (Charo and
Ransohoff, 2006). Downregulation of CCL2 may impair mononuclear
phagocyte mobilization and pathogen elimination, leading to pro-
longed infections, as suggested by studies on mice infected with
Streptococcus pneumoniae (Winter et al., 2007).
In summary, the persistence of HRSV in HEp-2 cells results from a
complex interaction of virus and cells, inwhich inhibition of apoptosis
and upregulation of prosurvival genes appear to play a pivotal role. In
addition, the persistence of HRSV in HEp-2 cultures leads to the
production of a particular pattern of chemokines and cytokines that
differs signiﬁcantly from that of a lytic infection, and which may be of
relevance to understand HRSV associated immunopathology.
Materials and methods
Cells and viruses
The human epithelial cell line HEp-2 was grown at 37 °C in 5% CO2
in Dulbecco's modiﬁed Eagle's medium (Lonza) supplemented with
10% fetal calf serum (Linus), 4 mM glutamine (Lonza), 100 U/ml
penicillin (Lonza) and 100 U/ml streptomycin (Lonza) (DMEM10).
The Long strain of HRSV was propagated in HEp-2 cells in DMEMwith
2% fetal calf serum (FCS), glutamine and antibiotics (DMEM2). Viruses
were puriﬁed from clariﬁed culture supernatants by polyethylene
glycol precipitation and centrifugation in a discontinuous sucrose
gradient, and titrated by plaque assay in HEp-2 cells as previously
described (Martinez et al., 2007). HEp-2 cells persistently infected
with the Long strain of HRSV were obtained by culturing of the few
cells surviving a lytic virus infection in DMEM10 at 37 °C in 5% CO2 and
passaged weekly at 1/3 dilution. At each passage of the persistently
infected culture, cells were scrapped off, disaggregated by thoroughly
pippeting, and virus was determined in the clariﬁed supernatant by
plaque assay.
Antibodies
Antibodies against G (02/1G, 021/2G, 021/8G, 021/9G and 021/
19G), F (2F, 47F, 56F and αF255–275), N (79N) and P (67P) proteins of
HRSV have been described previously (Garcia-Barreno et al., 1989;
Gonzalez-Reyes et al., 2001; Martinez et al., 1997). Mouse mono-
clonals against beta actin (ab8224), caspase-3 (ab13585), caspase-9
(ab28131), integrin beta 5 (ab55359) and CD47 (ab23814) were
obtained from abcam (UK). Mouse monoclonal anti-caspase-8
(AHZ0502) was purchased from Biosource. Rabbit polyclonal to
integrin alpha V (ab55991) was obtained from abcam (UK). Anti-
mouse IgG, horseradish peroxidase linked whole antibody (from
sheep) was purchased from GE Healthcare. Anti-mouse polyvalent
immunoglobulins (G, A, M)-FITC antibody produced in goat was
obtained from Sigma.
Gene expression proﬁling, cDNA microarrays and western-blots
HEp-2 cells were mock-infected or infected with puriﬁed virus
(Long strain) at an MOI of 3 pfu/cell in DMEM2. After 90 min of
adsorption, freshmediumwas added and cells were incubated at 37 °C
(lytic infection). After 24 h p.i., RNA was extracted with TRIZOL
reagent (Invitrogen) and further puriﬁed with the RNeasy kit
(Qiagen). A total of 40 μg of each RNA was reverse-transcribed using
Oligo-(dT)15 (Promega) and labeled with Cy3-dUTP (uninfected
samples) or Cy5-dUTP (infected samples) (GE Healthcare). The
labeled probes were puriﬁed by using the CyScribe GFX puriﬁcation
kit (GE Healthcare), hybridized to the 12 K human CNIO (SpanishNational Cancer Center, Madrid, Spain) cDNAmicroarray and analyzed
as previously described (Martinez et al., 2007). Differential gene
expression of persistently infected HEp-2 cells versus uninfected HEp-
2 cells was analyzed in a similar manner: the medium of uninfected
and persistently infected HEp-2 cells growing in DMEM10 was
changed to DMEM2. After 24 h in DMEM2, RNA was extracted,
reverse transcribed, labeled with Cy3-dUTP (uninfected cells) or Cy5-
dUTP (persistently infected cells) and competitively hybridized to the
CNIO cDNA microarray.
In some experiments protein cell extracts were done from cultures
infected under the same conditions as those used for RNA extraction.
Proteins were separated by SDS-PAGE and analyzed by western
blotting with antibodies indicated in each Figure.
Immunoﬂuorescence and ﬂow cytometry
For immunoﬂuorescence assays, cells growing in microchamber
culture slides were ﬁxed with cold methanol for 5 min followed by
cold acetone for 30 s. After air drying, unspeciﬁc binding sites were
saturated with 1% bovine serum albumin (BSA) in phosphate-buffered
saline (PBS), incubated with the hybridoma supernatants indicated in
the ﬁgure legends, and stained with a ﬂuorescein isothiocyanate-
labeled goat anti-mouse immunoglobulin antiserum (Sigma). For ﬂow
cytometry, cells were detached with PBS-10 mM EDTA, incubated for
20 min at 4 °C with a puriﬁed anti-F (101F) antibody conjugated with
the ﬂuorochrome Cy5, washed with PBS-2% FCS and ﬁxed with 1%
paraformaldehyde. Sample ﬂuorescence was measured on a FACS-
Canto ﬂow cytometer (BD Biosciences, San Jose, CA, USA) and
analyzed using FlowJo 7.5.2 sofware (TreeStar, San Carlos, CA).
Magnetic cell sorting
Cells from the persistently infected culture were sorted by using
MS columns following manufacturer's instructions (MACS). Brieﬂy,
cells were detachedwith PBS-10mMEDTA and labeledwith amixture
of antibodies 47F and 021/2G. Subsequently, the cells were magne-
tically labeled with Rat Anti-Mouse IgG1 MicroBeads (MACS). The cell
suspension was loaded onto a MACS MS column which was placed in
the magnetic ﬁeld of a MACS Separator. Under these conditions, the
magnetically labeled cells are retained in the column and the
unlabeled cells run through. After the removal of the column from
the magnetic ﬁeld, the magnetically retained cells were eluted in PBS-
0.5% BSA-2 mM EDTA and subjected to two additional rounds of
enrichment by loading onto new MS columns.
DNA fragmentation assays
Cells were irradiated with UV light for 3 min in PBS. After this
period, PBS was aspirated, freshmediumwas added and the cells were
incubated for 3 h at 37 °C. After the incubation period, cells were
detached with PBS-1 mM EDTA and DNAwas extracted with the Easy-
DNA kit of Invitrogen. Threemicrograms of DNAwas loaded into a 1.7%
agarose gel and DNA was visualized with ethidium bromide.
Alternatively, DNA fragmentation was determined by Cell Death
Detection ELISA (Roche), which is a photometric enzyme immunoas-
say for detection of cytoplasmic histone-associated DNA fragments
(mono- and oligonucleosomes) after induced cell death.
ELISA assays for chemokines
Semiconﬂuent 90 mm dishes of HEp-2 cells were infected with the
Long strain of HRSV in DMEM2 at a MOI of 3 pfu/cell. At the same
time, the culture medium of semiconﬂuent 90 mm dishes of
persistently infected cells was changed to DMEM2. Twenty-four
hours later, the amount of the chemokines CCL2/MCP-1, CCL3/MIP-
1α and CCL5/RANTES in the clariﬁed supernatant was determined by
40 I. Martínez et al. / Virology 388 (2009) 31–41solid phase sandwich ELISA kits following manufacturer protocols
(Biosource, KHC1011, KAC2201 and KHC1031).
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